NCT02862912View on ClinicalTrials.gov

Chloroprocaine Spinal Anesthesia for Cervical Cerclage (CP Spinal)

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 8, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Adverse Reaction to Spinal AnestheticMaternal Care for Cervical Incompetence
Interventions
DRUG

Chloroprocaine

Administered as a single injection or continuously through an indwelling catheter - 50 mg

DRUG

Bupivacaine

A dextrose Solution is usually given as an injection - 9 mg (1.4 ml)

DRUG

Fentanyl

15 mcg Fentanyl will be included int he spinal anesthetic in both groups

DRUG

Saline

Preservative free normal saline (0.3 ml) to bring the volume to \~ 2 ml

Trial Locations (1)

10032

New York Presbyterian Hospital, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT02862912 - Chloroprocaine Spinal Anesthesia for Cervical Cerclage (CP Spinal) | Biotech Hunter | Biotech Hunter